Last updated on April 23, 2014 at 11:29 EDT

Research and Markets Announces the Release of ‘Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities’

March 12, 2013

DUBLIN, March 12, 2013 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/jhtl3x/transdermal_pain) has announced the
addition of the “Transdermal Pain Management to 2016. Products, Markets, Forecasts and
Opportunities” report to their offering.

As life expectancy in the developed world increases and populations age, the incidence
and associated morbidity of chronic and acute pain is increasing and placing a higher
level of emphasis on pain management as a quality-of-life issue for patients and their
families. Responding to this trend, drug developers are increasingly turning to
transdermal formulations of pain management drugs. Because it has the potential to improve
drug therapy compliance, transdermal delivery addresses a key healthcare issue – one that
is particularly problematic in aging populations and developing economies. Currently
approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics.
These patches and gels will encounter competition from development-stage transdermal
formulations for a number of pain medications presently being marketed in oral or
parenteral form. Several of these development programs involve international partnerships
designed to take advantage of perceived opportunities in regional markets.


– Analyzes and evaluates the global market opportunity for transdermal pain management
and assesses the probable impact of evolving regulatory, economic and demand factors

– Assesses transdermal products approved or in development for the delivery of
therapeutic pain management drugs

– Provides detailed descriptions of pain management treatment segments, market
factors, and business strategies

– Forecasts transdermal pain management product demand to 2016 by geographic region
and product segment

– Profiles sector companies, their product development activities, supply chain
partners, business strategies, and collaboration partners

Key Topics Covered

– Executive Summary

– Scope and Definitions

– The Pain Management Market Opportunity

– Evolution in Pain Management Guidelines

– Transdermal Drug Delivery Dynamics

– Transdermal Pain Management Patches

– Transdermal Pain Management Product Assessments and Market Prospects

– FDA Approved Transdermal Pain Management Products

– Transdermal Pain Management Market Factors

– Market Forecasts

– Market Participant Profiles

For more information visit


        Research and Markets
        Laura Wood, Senior Manager.
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +353-1-481-1716
        Sector: Pharmaceuticals

SOURCE Research and Markets

Source: PR Newswire